Cargando…
Differences in N-glycosylation of recombinant human coagulation factor VII derived from BHK, CHO, and HEK293 cells
BACKGROUND & METHODS: Recombinant factor VII (rFVII), the precursor molecule for recombinant activated FVII (rFVIIa), is, due to its need for complex post translational modifications, produced in mammalian cells. To evaluate the suitability of a human cell line in order to produce rFVII with pos...
Autores principales: | Böhm, Ernst, Seyfried, Birgit K., Dockal, Michael, Graninger, Michael, Hasslacher, Meinhard, Neurath, Marianne, Konetschny, Christian, Matthiessen, Peter, Mitterer, Artur, Scheiflinger, Friedrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574471/ https://www.ncbi.nlm.nih.gov/pubmed/26382581 http://dx.doi.org/10.1186/s12896-015-0205-1 |
Ejemplares similares
-
Expression of recombinant human coagulation factors VII (rFVII) and IX (rFIX) in various cell types, glycosylation analysis, and pharmacokinetic comparison
por: Böhm, Ernst, et al.
Publicado: (2011) -
Differences in the production of hyperglycosylated IFN alpha in CHO and HEK 293 cells
por: Gugliotta, Agustina, et al.
Publicado: (2013) -
HEK293T cell lines defective for O-linked glycosylation
por: Termini, James M., et al.
Publicado: (2017) -
Influence of glutamine on transient and stable recombinant protein production in CHO and HEK-293 cells
por: Rajendra, Yashas, et al.
Publicado: (2011) -
Predicting Transiently Expressed Protein Yields: Comparison of Transfection Methods in CHO and HEK293
por: Porosk, Ly, et al.
Publicado: (2022)